Burn injuries can be physically and psychologically traumatic.


BURN - Hero.png

Key goals of burn treatment

The aim of burn wound management is to remove non-viable tissue, prevent infection, manage exudate and achieve wound closure as quickly as possible1. Moist wound healing is recommended over exposure treatment of burn wounds, as this is associated with improved healing and less pain.

Overall aims of wound dressings for burn injuries1:

  • Maintain a moist wound environment to aid healing.
  • Absorb exudate - a burn wound produces exudate, which may be copious in the first 24-48 hours after injury.
  • Provide a barrier to infection.
  • Decrease wound pain.

 

Burn wound management1:

  • Burns should be reviewed within 48 hours after injury reassess the depth of the wound in cases where this may have been unclear at presentation, and to change the initial dressing, which at this point is likely to be soaked
  • As healing progresses, dressing changes should be reduced to minimise disturbance to the wound
BURN - Image callout.png
Prepare, Protect, Progress.png

VERSAJET II

PREPARE - Precision excision and tissue preservation

Use of the VERSAJET◊ Hydrosurgery System for deep partial-thickness (DPT) and full-thickness (FT) burns undergoing skin grafting resulted in improved scar quality at one year, compared with conventional debridement.

Versajet II custom.png


ACTICOAT

PROTECT - Act with certainty

A large surface area of NCS structure enables sustained release of silver into the wound fluid, while the dressing helps to promote and retain a moist environment, when used with an appropriate secondary dressing. Shown to deliver sufficient silver at a consistent concentration to remain bactericidal.**4-12

BURN - ACTICOAT.png


PROGRESS

Progress healing without delay 

The risk of scar formation increases as healing is delayed.3
Treatments that increase the rate of re-epithelialisation have thepotential to prevent scarring in some wounds.4
The rate of re-epithelialisation can be enhanced by removing abarrier such as bacterial contamination.5

RENASYS◊ TOUCH Negative Pressure Wound Therapy System

  • Clinically effective for a range of chronic and acute wounds across a variety of care settings3
  • Adjustable compression rate and variable intermittent mode allow for tailoring the therapy to an individual patient’s needs and comfort 2,4
  • The leak gauge is designed to aid clinicians in locating and resolving air leaks 2
  • Detailed pump activity log5.
  • Easy-to-use onscreen quick reference guide supports device operation5.
  • Up to 14 hours of battery life on a single charge.6
Renasys touch custom.png

BIOBRANE - Temporary Synthetic Skin Dressing

  • Increases the speed of healing and epithelisation, compared to silver sulphadiazine1-3
  • Allows direct wound inspection.4,5
  • In a study where 32 patients were treated with BIOBRANE, a reduced length of hospital stay was reported associated with its adoption*
  • Is flexible and conforms to surface irregularities potentially allowing joint movement.4,5,7
  • Can be used on extensive body surface area wounds.8,9
  • Can be used in paediatric populations and is easy to apply.4,10,11
  • Limited number of dressing changes required compared to other treatment options.1,4,12
Biobrane custom.png

PELNAC Artificial Dermis

  • Good engraftment of secondary skin graft, preserving aesthetic outcome.1-6
  • Enables extremely thin skin graft, keeping donor-site damage in check.
  • Minimal post-treatment contracture or pigment deposition.
  • The collagen layer uses atherocollagen. Atherocollagen iscreated by enzymatically treating collagen derived from thetendons of Japanese-bred pigs to remove its telopeptide regions,attenuating its antigenicity.
  • The collagen sponge is flexible, providing superior adhesion touneven wound surfaces.
Pelnac.png

 

Citations

1. Westaim Report Ref. £010322 ‘Seveb Day Efficacy to ACTICOAT 7 Dressings Against Multiple Organisms’.

2. Daubney L. Silver Release Testing of ACTICOAT Flex 7 Dressings. Report reference DS/08/062/R2.

3. Westaim Report Ref. #971030 ‘The Antimicrobial Activity of Westaim’s ACTICOAT Silver Coated Dressing against Clinically Relevant Organsisms over an Extended Period of Time’.

4. Daubney L. Silver Release Testing of ACTICOAT Flex 3 Dressings. Report reference DS/08/078/R2.

5. Westaim Report Ref. #001213 ‘Long Term Comparative Evaluation of Silverlon and ACTICOAT 7 Dressings’ Activities Against MRSA’.

6. Driffield K. Antimicrobial activity testing of ACTICOAT Flex 7 dressings against a broad spectrum of wound pathogens, Dataon file 0810012, Smith & Nephew.

7. Driffield K. Antimicrobial activity of ACTICOAT Flex 7 dressings in a seven-day repeat challenge, Data on file 0810013, Smith & Nephew.

8. Fong J, Wood F, Fowler B. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns. 2005 Aug;31(5):562-7.

9. Driffield K. Antimicrobial Activity of ACTICOAT Flex 3 against a Broad Spectrum of Wound Pathogens, Data on File reference 0810016.

10. Driffield K. Antimicrobial activity of ACTICOAT Flex 3 in a three-day repeat challenge, Data on file 0810017, Smith & Nephew.

11. Driffield K. Antimicrobial activity testing of ACTICOAT Flex 7 dressings against a broad spectrum of wound pathogens using log reduction, report reference WRP-TW 141-022.

12. Wright JB, Lam K,Burrell RE. Wound management in an era of increasing bacterial antibiotic resistance:a role for topical silver treatment. AM J Infect Control. 1998 Dec;26(6):572-7.

13. Wright JB, Lam K, Hansen D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control. 1999 Aug;27(4):344-50.

14. Westaim (Sherritt) Report Ref: 93/001 ‘Broad Spectrum Efficacy’.

15. Driffield K. ACTICOAT Flex 3 has antimicrobial activity in 30 minutes, Data on file 0810018, Smith & Nephew.

16. Driffield K. ACTICOAT Flex 7 has antimicrobial activity in 30 minutes, Data on file 0810014.

Title

Text

Explore